Skip to content

Effect of compound lidocaine ointment on oral secretion during recovery period of laryngeal mask general anesthesia

Effect of compound lidocaine ointment on oral secretion during recovery period of laryngeal mask general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035364
Enrollment
Unknown
Registered
2020-08-09
Start date
2020-08-10
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ophthalmic diseases

Interventions

Lidocaine ointment Group:Application of lidocaine ointment on laryngeal mask
control group:Laryngeal mask is not treated

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sun University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients who will undertake selective ophthalmic surgery; 2. Meet the standard of American Society of Anesthesiologists'(ASA) physical status 1 to 2; 3. Aged 18 to 60 years; 4. BMI 18 to 25 kg/m2; 5. Estimated duration of anesthesia more than 30min.

Exclusion criteria

Exclusion criteria: 1. ASA over grade III; 2. Those who have contraindication of laryngeal mask; 3. There was a history of upper respiratory tract infection one week before operation/Chronic pharyngitis/Severe gastroesophageal reflux/Morbid obesity/open mouth too small/There were abnormal oropharyngeal lesions/Cardiopulmonary diseases/Patients with congenital or idiopathic methemoglobinemia and those who are receiving other drugs (such as sulfonamides) that can cause methemoglobinemia; 4. Local anesthetic allergy; 5. Laryngeal mask intubation times more than 2 times, laryngeal mask alignment is not good leakage; 6. The operation time was less than 30min; 7. Atropine was used during the operation; 8. The researchers believe that there are any factors affecting the subjects' participation in the trial or the evaluation of the results.

Design outcomes

Primary

MeasureTime frame
Amount of oral secretions during recovery period;

Secondary

MeasureTime frame
Absorption and action site of compound lidocaine ointment;Operation time;Extubation time;hemorrhage;Residence time of PACU;Hoarseness;sore throat;vomit;Incidence of dysphagia;Ingredients in nasolacrimal duct secretion;

Countries

China

Contacts

Public ContactYao-Yi Liang

Zhongshan Ophthalmic Center, Sun Yat-sun University

178016249@qq.com+86 13560214570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026